Optimal Volume of Bupivacaine in Adductor Canal Nerve Block in Patients Undergoing Unilateral Cruciate Ligament Reconstruction Surgery

Trial Profile

Optimal Volume of Bupivacaine in Adductor Canal Nerve Block in Patients Undergoing Unilateral Cruciate Ligament Reconstruction Surgery

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Oct 2016

At a glance

  • Drugs Levobupivacaine (Primary)
  • Indications Anaesthesia; Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Oct 2016 Planned End Date changed from 1 Dec 2016 to 1 Mar 2017.
    • 11 Oct 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Dec 2016.
    • 11 Oct 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top